Compare ImmunityBio Inc. Common Stock (IBRX) vs MiniMed Group Inc. Common Stock (MMED) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs MiniMed Group Inc. Common Stock — how do they compare? ImmunityBio Inc. Common Stock trades at $9.99 (market cap $10.33B), while MiniMed Group Inc. Common Stock trades at $19.57 (market cap $5.38B). The key difference: ImmunityBio Inc. Common Stock is the larger of the two by market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, MiniMed Group Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and MiniMed Group Inc. Common Stock for 0 Days on average.
| IBRX | MMED | |
|---|---|---|
Market Cap | $10.33B | $5.38B |
Volume | 11,745,198 | 9,619,294 |
Sector | Health | Health |
52-Week High | $11.55 | $23.84 |
52-Week Low | $1.98 | $10.80 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.79B | $5.18B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About MiniMed Group Inc. Common Stock
MiniMed develops, manufactures, and markets diabetes-management technologies. Its products include insulin-delivery systems, continuous glucose monitors, smart insulin pens, and related software.
Read more on MMED →
